Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou 310058, China; Zhejiang Provincial Key Laboratory of Tissue Engineering and Regenerative Medicine, Hangzhou 310058, China; Institute of Bionanotechnology and Tissue Engineering, College of Biology, Hunan University, Changsha 410082, China.
College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, China.
Acta Biomater. 2018 Jan 15;66:141-156. doi: 10.1016/j.actbio.2017.09.036. Epub 2017 Sep 28.
UNLABELLED: Poor tendon repair is often a clinical challenge due to the lack of ideal biomaterials. Electrospun aligned fibers, resembling the ultrastructure of tendon, have been previously reported to promote tenogenesis. However, the underlying mechanism is unclear and the aligned fibers alone are not capable enough to commit teno-differentiation of stem cells. Here, based on our observation of reduced expression of histone deacetylases (HDACs) in tendon stem/progenitor cells (TSPCs) cultured on aligned fibers, we proposed a strategy to enhance the tenogenesis effect of aligned fibers by using a small molecule Trichostatin A (TSA), an HDAC inhibitor. Such a TSA-laden poly (l-lactic acid) (PLLA) aligned fiber (A-TSA) scaffold was successfully fabricated by a stable jet electrospinning method, and demonstrated its sustained capability in releasing TSA. We found that TSA incorporated aligned fibers of PLLA had an additive effect in directing tenogenic differentiation. Moreover, the in situ implantation study in rat model further confirmed that A-TSA scaffold promoted the structural and mechanical properties of the regenerated Achilles tendon. This study demonstrated that HDAC was involved in the teno-differentiation with aligned fiber topography, and the combination of HDAC with aligned topography might be a more efficient strategy to promote tenogenesis of stem cells. STATEMENT OF SIGNIFICANCE: Electrospun aligned fibers, resembling the ultrastructure of tendon, have been previously reported to promote tenogenesis. However, the underlying mechanism is unclear and the aligned fibers alone are not capable enough to commit teno-differentiation of stem cells. The uniqueness of our studies are as follows, based on our observation of reduced expression of histone deacetylases (HDACs) in tendon stem/progenitor cells (TSPCs) cultured on aligned fibers, we proposed a strategy to enhance the tenogenesis effect of aligned fibers by using a small molecule Trichostatin A (TSA), a HDAC inhibitor. Such a TSA-laden poly (l-lactic acid) (PLLA) aligned fiber (A-TSA) scaffold was successfully fabricated by a stable jet electrospinning method, and demonstrated its sustained capability in releasing TSA. The incorporation and subsequent release of bioactive small molecule TSA into electrospun aligned fibers allows a controllable manner for both biochemical and physical regulation of tenogenesis of stem cells both in vitro and in vivo. Collectively, the present study provides a model of "translating the biological knowledge learned from cell-material interaction into optimizing biomaterials (from Biomat-to-Biomat)".
未加说明:由于缺乏理想的生物材料,肌腱修复往往是临床面临的挑战。先前的研究表明,具有类似肌腱超微结构的静电纺丝纤维能够促进肌腱形成。然而,其潜在机制尚不清楚,并且单独的纤维排列不足以促使干细胞向肌腱分化。在这里,基于我们观察到在纤维排列上培养的肌腱干/祖细胞(TSPCs)中组蛋白去乙酰化酶(HDACs)表达降低,我们提出了一种通过使用小分子 Trichostatin A(TSA)增强纤维排列的肌腱形成作用的策略,TSA 是一种组蛋白去乙酰化酶抑制剂。通过稳定射流静电纺丝方法成功制备了载有 TSA 的聚(L-乳酸)(PLLA)排列纤维(A-TSA)支架,并证明其具有持续释放 TSA 的能力。我们发现,掺入 PLLA 排列纤维的 TSA 在指导肌腱形成分化方面具有附加作用。此外,大鼠模型的原位植入研究进一步证实,A-TSA 支架促进了再生跟腱的结构和机械性能。这项研究表明,HDAC 参与了与纤维排列拓扑结构相关的肌腱形成,而将 HDAC 与纤维排列拓扑结构相结合可能是一种更有效的策略,可促进干细胞的肌腱形成。
意义声明:先前的研究表明,具有类似肌腱超微结构的静电纺丝纤维能够促进肌腱形成。然而,其潜在机制尚不清楚,并且单独的纤维排列不足以促使干细胞向肌腱分化。我们研究的独特之处在于,基于我们观察到在纤维排列上培养的肌腱干/祖细胞(TSPCs)中组蛋白去乙酰化酶(HDACs)表达降低,我们提出了一种通过使用小分子 Trichostatin A(TSA)增强纤维排列的肌腱形成作用的策略,TSA 是一种组蛋白去乙酰化酶抑制剂。通过稳定射流静电纺丝方法成功制备了载有 TSA 的聚(L-乳酸)(PLLA)排列纤维(A-TSA)支架,并证明其具有持续释放 TSA 的能力。将生物活性小分子 TSA 掺入到静电纺丝纤维中,并随后释放出来,使得在体外和体内都能够以可控的方式对干细胞的肌腱形成进行生化和物理调节。总的来说,本研究提供了一个“将从细胞-材料相互作用中获得的生物学知识转化为优化生物材料(从 Biomat 到 Biomat)”的模型。
Int J Biol Macromol. 2021-2-15
Tissue Eng Part C Methods. 2018-5-24
Pharmacol Rev. 2025-6-26
Small Sci. 2021-5-25
Front Cell Dev Biol. 2025-3-13
Bioact Mater. 2025-2-20
Life Med. 2023-7-20
Pharmaceuticals (Basel). 2024-5-10
Genes Dis. 2023-7-7